SMAD3 and breast cancer: In primary breast tumors, YAP suppresses SMAD family member 3 (Smad3) activity, enhancing the survival and self-renewal of tumor-initiating cells, which increases the risk of breast cancer recurrence and metastasis (Sun et al., 2016).